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Background: Cystic renal cell carcinoma (CRCC) is relatively rare; CRCC is frequently misdiagnosed as a benign
renal cyst. CRCC carries an excellent prognosis following surgical treatment. The aim of our study was to summarize
the management of CRCC and to characterize the prognosis of affected patients.
Methods: A retrospective study of 67 patients with CRCC was conducted at our center between January 2005 and
April 2013. Patient prognosis as well as the clinical manifestations, imaging characteristics, treatment, and
pathologic features of CRCC were summarized based on available medical record data.
Results: We identified 67 cases of CRCC, representing 2.5% of all renal cell carcinoma cases. The tumor was
discovered incidentally in 70% of the cases. Ultrasonography was found to be a useful screening tool, but
computed tomography remains the imaging study of choice for identifying malignant features. Magnetic resonance
imaging can be used in equivocal cases. Regarding treatment, radical nephrectomy was performed in 52% of the
cases, and partial nephrectomy was selected in the remaining 48% of cases. None of the 46 patients (68% of the
study group) available for follow-up showed any evidence of recurrence.
Conclusions: CRCC is an uncommon subtype of renal cell carcinoma, occurring in 2.5% of cases. CRCC carries an
excellent prognosis after surgical treatment. Partial nephrectomy should be regarded as the preferred surgical
technique for CRCC.
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Cystic renal cell carcinoma (CRCC) is relatively rare; it
represents a special subtype of renal cell carcinoma
(RCC) associated with a low nuclear grade and stage
and an excellent prognosis regardless of tumor size.
However, CRCC is frequently misdiagnosed as a benign
renal cyst because it shares similar clinical manifesta-
tions and imaging characteristics. In the present study,
we retrospectively analyzed 67 CRCC cases treated at
our center; we summarize patient prognosis and the
clinical manifestations, imaging characteristics, treat-
ment, and pathologic features of CRCC based on* Correspondence: jinbaiye1964@aliyun.com
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unless otherwise stated.medical record data. To our knowledge, this represents
the largest series of CRCC cases, and it includes four
cases with other concurrent RCCs.Methods
We reviewed our center’s pathology files and identified all
RCC cases with a cystic component occurring between
January 2005 and April 2013; 67 cases of CRCC were
identified. Clinical data, including clinical and radio-
graphic characteristics, surgical management, pathologic
features, and outcomes, were retrospectively reviewed.
Prior to surgery, patients underwent renal ultrasonog-
raphy, abdominal computed tomography (CT), and mag-
netic resonance imaging (MRI) for evaluation of each
patient’s overall and renal status. All cystic masses were
graded according to the Bosniak classification system [1],
and the pathological specimens were staged according totd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 The character of cystic renal cell carcinoma
Features Value %










Upper pole 24 36
Lower pole 28 42
The remaining 15 22
Surgery
Open radical nephrectomy 19 28
Open partial nephrectomy 12 18
Laparoscopic radical nephrectomy 9 13
Laparoscopic partial nephrectomy 20 30
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[2]. Additionally, a tumor nuclear grade was assigned
using the Fuhrman system [3]. All histopathologic slides
were reanalyzed by a single pathologist specialized in geni-
tourinary pathology. The size of the neoplasm was mea-
sured grossly using the maximum diameter. Clinical
follow-up data was obtained from patients’ records as well
as referring physicians; telephone interviews were con-
ducted for patients who lacked clinical follow-up within
the past 6 months. Finally, all data were analyzed using ei-
ther the Student’s t-test or a chi-square test.
The Medical Ethics Committee of the First Affiliated
Hospital of Medical College, Zhejiang University ap-
proved this retrospective study; the study was exempted
from the requirement to obtain informed consent from
the other 63 patients (not including 4 cases of concur-
rent RCCs) in consideration of the nature of the study.
Written informed consent was obtained from the 4 pa-
tients (4 cases of concurrent RCCs) for publication of
this manuscript and accompanying images.
Results
We identified 67 cases of CRCC, which represented
2.5% of the 2679 cases of RCC resected at our institu-
tion between January 2005 and April 2013; 217 out of
all 2679 RCC patients had concurrent cystic renal le-
sions, and 4 out of the 67 CRCC patients had other
concurrent RCCs (Tables 1 and 2). For the 67 patients
diagnosed with CRCC on final pathology, the average
age at diagnosis was 56.0 years, with a range of 24–83
years; the average age was 58.2 years (n =46) for men
and 54.7 years for women. The tumor was incidentally
found during evaluation for an unrelated condition in
47 patients (70%), whereas a renal tumor was suspected
in 20 (30%). Left renal cystic masses were identified in
32 patients; the remaining 35 patients had right renal
cystic masses. The masses were located in the upper
pole in 24 patients, the lower pole in 28, and other lo-
cations in the remaining 15. Renal ultrasound scans
were available in all 67 cases (Figure 1A, B) and dem-
onstrated a complex cystic mass in 49 cases. Renal CT
scans were performed in 62 patients (Figure 1C), and a
possible CRCC was reported in 48. Additional investi-
gation included MRI in 21 patients (Figure 1D); an en-
hancing, cystic renal lesion suggestive of malignancy
was identified in 18.
The patients underwent the following surgical proce-
dures: open radical nephrectomy (n =19), open partial
nephrectomy (n =12), laparoscopic radical nephrectomy
(n =9), laparoscopic partial nephrectomy (n =20), and a
second anesthesia for radical nephrectomy (n =7, in-
cluding 3 patients with an intraoperative frozen section
diagnosis of a renal cyst and 4 patients without intraop-
erative frozen section analysis; the final pathologicalresult was CRCC for all of these cases). Prior to 2010, 3
of 14 patients underwent partial nephrectomy. After
2010, 29 of 53 cases underwent partial nephrectomy.
Fifty-three cases (79%) were nuclear grade I, 12 cases
(18%) were nuclear grade I-II, and 2 (3%) were nuclear
grade II (Figure 2). Among the 67 patients, 25 (37%)
had stage T1a disease, 35 (52%) had stage T1b disease,
and 7 (10%) had stage T2a disease.
All patients had uneventful surgical recoveries. Forty-
six patients were followed for a mean time of 42 months
(range: 6–84 months); among these, 7 patients (who
were initially misdiagnosed as having benign tumors on
preoperative or intraoperative pathology but confirmed
as having malignant tumors on postoperative path-
ology) were followed for 56 months (range: 35–77
months). Their overall outcomes were excellent: there
was no evidence of neoplastic recurrence or metastasis.
Four cases died of non-neoplastic diseases.
Table 2 The character of cystic renal cell carcinoma concurrent renal cell carcinomas
Pt. No. Age (yr) Sex Mass location (size) Side/Treatment Follow-up (mo) Outcome
1 48 M Upper pole: cystic(4.5 × 3.0 cm) Left radical nephrectomy 36 No evidence of disease
Lower pole: solid(2.8 × 2.0 cm)
2 59 M Upper pole: cystic(2.5 × 2.0 cm) Left partial nephrectomy 29 No evidence of disease
Lower pole: solid(3.5 × 3.0 cm)
3 50 F Mid pole: solid (2.0 × 2.0 cm) Right radical nephrectomy 8 No evidence of disease
Lower pole: cystic (4.0 × 4.0 cm)
4 37 M Mid pole: solid(3.0 × 3.0 cm) Left partial nephrectomy 8 No evidence of disease
Mid pole: cystic(2.0 × 2.0 cm)
Chen et al. BMC Urology 2014, 14:87 Page 3 of 6
http://www.biomedcentral.com/1471-2490/14/87Discussion
Cystic degeneration of the kidney is very common among
renal lesions. However, CRCC is rare, accounting for only
1% to 4% of all RCCs in previous studies [4-6]; in our
series, CRCC represented 2.5% of the RCCs. Corica et al.
found that 83% of CRCC cases were diagnosed inciden-
tally [5]. The results of our study are in agreement, show-
ing that CRCC is more likely to be discovered incidentally
(on abdominal imaging for unrelated conditions) than as a
result of tumor-related symptoms.
Accurate diagnosis is sometimes difficult because
CRCC, conventional RCC with cystic change, and benign
renal cystic disease have similar imaging characteristics.
Ultrasonography has been found to be a useful screeningFigure 1 Ultrasound, computed tomography, and magnetic resonanc
(patient 2). B) Ultrasound: Lower pole renal solid mass (patient 2). C) Comp
the upper pole (patient 2). D) T1-weighted magnetic resonance imaging: C
the middle part of the kidney.tool. On sonography, CRCC appears as a cystic or cystic-
solid structure with thick capsule walls, hyperechoic in-
ternal septa, and heterogeneous echogenicity [7,8]; duplex
Doppler ultrasound may or may not display increased
blood flow in the walls of the cyst. Computed tomog-
raphy can provide richer diagnostic information than
ultrasonography. On CT, CRCC appears as a cystic or
mixed cystic-solid mass with thick and irregular enhan-
cing cyst walls, with or without calcification. According
to the literature, thick calcification or crescent calcifica-
tion has more significance in the diagnosis of CRCC.
The septa tend to be of uneven thickness (they are
often >1 mm in diameter), and nodular thickening can
appear at the junctions with the capsule walls. Thee images. A) Ultrasound: Upper pole complex cystic renal mass
uted tomography: Lower pole renal mass with a concurrent cyst in
omplex cystic mass with thick and irregular enhancing cyst walls in
Figure 2 Pathological images from patient 2. A) Cystic renal cell carcinoma. Cysts are lined by clear cells with uniform nuclei. Clusters of clear
cells are present in the septal walls. B) Renal clear cell carcinoma. The tumor consists of sheet-like, solid clear cells. H&E × 100.
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blood clots, giving it an uneven appearance on CT scan.
The lesions typically have unclear borders adjacent to
the renal parenchyma. In our study, the lesions were de-
scribed as suggestive of CRCC in 48 out of the 67 patients.
Computed tomography is less reliable in evaluating CRCC
lesions under 4 cm in size, because a small lesion may ap-
pear to be a solid mass [9]. Furthermore, CT may not be
able to differentiate CRCC from necrotic RCC [10]. If the
determination of benign versus malignant renal cystic dis-
ease is unclear, MRI evaluation can provide additional in-
formation. We found MRI to be superior to CT for such
differentiation, as did Adey el al. in a previous study [11].
The differential diagnoses for CRCC include RCC with
cystic change, hereditary leiomyomatosis manifesting as
a cystic renal lesion, cystic nephroma, clear cell papillary
RCC, and other cystic lesions of the kidney. These cystic
tumors are extremely difficult to distinguish based on
clinical, radiological, and gross features, and they can
cause a diagnostic dilemma. Cystic renal cell carcinoma
is a predominantly cystic lesion with a small solid com-
ponent (25% or less). Renal cell carcinoma usually pre-
sents as a solid mass; however, in 10–22% of cases, it
appears as a unilocular or multilocular cystic mass on
imaging studies. Four mechanisms have been described
to account for RCC with cystic features: intrinsic uni-
locular cystic growth (papillary cystic adenocarcinoma),
intrinsic multilocular cystic growth, tumor necrosis
resulting in cyst formation (pseudocyst), and tumor ori-
gination in a preexisting simple renal cyst. Typically,
hereditary leiomyomatosis-associated renal tumors dis-
play type 2 papillary architecture, but they can show a
variety of patterns, including cystic, tubular-papillary,
tubular, and solid. Cystic nephroma consists of a circum-
scribed mass of cysts with intervening fibrous septa, oc-
casionally areas of calcification, and regions of cellular
bland ovarian-like stroma. The cysts are lined by a single
layer of flattened low cuboidal or hobnail benignepithelium. Clear cell papillary RCC is usually cystic,
with cyst walls lined by clear cells; however, much of the
tumor typically exhibits papillary architecture, a feature
not found in CRCC. It is important to avoid misdiagnos-
ing CRCC as conventional clear cell RCC, which is one
of the reasons that we chose to present this series of
CRCC cases.
Because of potential tumor rupture or spillage, the
traditional treatment for CRCC has been radical neph-
rectomy. However, CRCCs tend to be smaller tumors at
initial diagnosis and to have a lower T stage and nuclear
grade; therefore, these lesions may be more amenable to
partial nephrectomy. Because of the benign nature of
CRCC, along with accumulating experience with partial
nephrectomies and improved surgical techniques, in-
creasing numbers of surgeons are choosing partial neph-
rectomy as the first-choice therapy for CRCC. Gong
et al. suggested that a partial nephrectomy should be
considered when a complex multicystic renal mass with
enhanced density is observed, particularly as CRCC— like
conventional RCC— is often located in the renal polar re-
gions, which makes a partial nephrectomy approach feas-
ible [12]. Based on their recent findings, You et al.
indicated that 96% of patients with benign cysts or CRCCs
greater than 4 cm in size might be able to avoid radical
nephrectomy and instead undergo partial nephrectomy
[13]. At our center, partial nephrectomy has been widely
performed for renal carcinoma since 2010. In the present
study, 3 of the 14 patients admitted before 2010 under-
went a partial nephrectomy, whereas 29 of 53 cases admit-
ted after 2010 received a partial nephrectomy.
Intraoperative pathological examination may facilitate
accurate diagnosis and help clinicians to modify their
surgical approach. However, a minority of CRCC cases
may not show any malignant signs on intraoperative
pathology. In our study, three CRCC cases were intraop-
eratively diagnosed as simple renal cysts; these patients
required a second anesthesia for radical nephrectomy.
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of surgery, confusion may remain in the determination
of benign versus malignant disease. The cause of inexpli-
cit pathology on frozen biopsy and aspiration is probably
due to compression or ischemia of the cyst wall. If there is
any intra-operative doubt regarding the absence of neo-
plasm, the renal cystic mass should be removed with clear
margins. If suitable, a renal sparing approach should be
considered. Currently, we are attempting to implement
this philosophy to all patients.
In our series, 217 of the 2679 RCC patients had con-
current cystic renal lesions, and 4 of the 67 CRCC pa-
tients had other concurrent RCCs. The kidneys are
prone to a variety of cystic disorders that include devel-
opmental, acquired, and neoplastic lesions. However, the
synchronous occurrence of two different tumors within
the same kidney is a rare event. With the widespread
use of ultrasonography, CT, and MRI, such coexisting
tumors are now more readily diagnosed. Two or three
concurrent renal cell tumors have been reported in cases
involving hybrid tumors [14] and Birt-Hogg-Dubé syn-
drome, but also in sporadic other cases [15]. A recent
report by Tyritzis et al. described the combination of
two dissimilar RCC subtypes: a chromophobe lesion in
the upper pole and a clear cell lesion in the lower pole
of the same kidney [16]. The etiology and pathogenesis
of such multiple tumors remain unclear. It has been hy-
pothesized that concurrent tumors can arise from tissues
with similar embryological origin when they are simul-
taneously affected by factors such as carcinogens or hor-
mones. The authors assumed that different renal tumors
could arise from cancer stem cells that follow dissimilar
differentiation pathways regulated by tissue microenvi-
ronmental interactions [17]. Other hypotheses are the
evolution from one subtype to another (for example,
oncocytomas possess the ability to evolve into papillary
carcinomas [18]) or the transformation of one malignant
renal tumor to another type. The presence of multifocal
renal lesions complicates their surgical management. In
our opinion, any secondary lesion identified within a
kidney should be thoroughly evaluated to minimize the
chance of leaving a malignancy behind following a
nephron-sparing procedure. If we would choose a partial
nephrectomy to treat a solid renal lesion, we should also
choose a partial nephrectomy, not an unroofing proced-
ure, to treat non-simple renal cysts, which might avoid a
second surgery.
Murad et al. suggested Fuhrman nuclear grade 1 as a
defining criterion for CRCC [4]. However, we — along
with other investigators — do not favor including grade
as a diagnostic characteristic for these tumors [19]. In
our study, although most tumors were Fuhrman grade 1,
we encountered some CRCC tumors of nuclear grades I-
II and II as well.Cystic renal cell carcinoma carries a better prognosis
than other RCCs because of its low nuclear grade and
TNM stage regardless of tumor size [20]. The 10-year
survival rate and non-recurrence rate after surgery have
been reported as 97.3% and 90.3%, respectively [21]. To
date, the overall survival in our patient population is
more than 90%; with 6–84 months of follow-up, there
have not been any signs of local or distant recurrence.
Patients initially misdiagnosed as having a benign
tumor on pre- or intra-operative pathology that are
subsequently diagnosed with a malignant tumor post-
operatively should undergo remedial measures (radical
nephrectomy) as soon as possible; this situation oc-
curred in 7 cases from our series. Intraoperative cyst
rupture during resection did not have any clinical im-
pact on patients’ outcomes after radical nephrectomy;
these patients’ outcomes were excellent, with no evi-
dence of neoplastic recurrence or metastasis. Because
of the rarity of this disease entity and the limited num-
ber of patients reported in the literature and in our
study, additional research is needed to further show the
diagnostic, pathologic, and prognostic characteristics of
CRCC.
Conclusions
Our results indicate that CRCC is uncommon. CRCC
carries an excellent prognosis following surgical treatment.
Partial nephrectomy should be regarded as the preferred
surgical technique in the management of CRCC.
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